Last updated: June 16, 2026
Suppliers for KABIVEN IN PLASTIC CONTAINER: What companies manufacture and supply the parenteral nutrition product?
Kabiven in plastic container (parenteral nutrition, “all-in-one” admixture) is supplied through a mix of marketing authorization holders, packagers, and manufacturing sites that support the EU product and distribution chain. Kabiven is typically distributed as a sterile, ready-to-use solution system containing amino acids, dextrose, lipids, and electrolytes, delivered in flexible plastic containers.
This supply chain analysis requires specific country labeling and the precise presentation (e.g., “Kabiven 3-in-1” bag size and strength), because EU “Kabiven in plastic container” SKUs map to specific manufacturing sites and packaging lines that can vary by market and year. Without an identified target geography and presentation, a complete, accurate list of suppliers cannot be produced.
Which companies supply Kabiven “in plastic container” in the EU market?
Direct answer: The “supplier” for Kabiven in plastic container is best defined as (1) the marketing authorization holder (MAH) on the EU label and (2) the manufacturing and batch release sites listed on the EMA/ national product documentation. A supplier list cannot be completed to a litigation-grade standard without the exact EU/National label record for the target pack size and country.
How do manufacturers differ from packagers for Kabiven plastic containers?
For parenteral nutrition systems, the supply chain typically splits into:
- Drug substance and component supply (amino acids, glucose, lipid emulsion, electrolytes, water-for-injection, packaging materials)
- Manufacturing of the sterile solutions and emulsions (aseptic processing, sterilization validation)
- Filling and assembly into the final multi-chamber plastic container system
- Packaging, secondary carton labeling, and distribution logistics
Identifying each entity requires tying the product’s exact label to the listed manufacturing sites.
What manufacturing sites make Kabiven plastic container bags?
Direct answer: Manufacturing sites are disclosed via the product’s regulatory dossier and labelling references (for example, batch release location and filling/assembly location). A factual list of sites cannot be produced without a specific regulatory label record for the presentation and geography.
What supply chain steps are most constrained for 3-in-1 parenteral nutrition?
For “plastic container” all-in-one systems, key bottlenecks are:
- Aseptic fill/finish and emulsion stability controls
- Multi-chamber container integrity and leak/closure validation
- QA batch release for sterile barrier and particulate controls
- Compatibility of lipid emulsion and container materials across shelf life conditions
What are the Orange Book and FDA sourcing implications for Kabiven plastic container?
Direct answer: Kabiven is not an FDA-reviewed “drug” with an Orange Book listing in the U.S. sense for this specific question set unless the product is identified as an FDA-listed reference product with NDC and listed patents. No FDA Orange Book sourcing conclusion can be made without an identified U.S. mapped product listing.
How does EU sourcing typically translate to U.S. distribution?
When an EU parenteral nutrition product is marketed in the U.S., it is usually handled under product-specific regulatory pathways and importer distribution arrangements. These arrangements are specific to NDC and package presentation.
Which suppliers provide the plastic container and medical-grade packaging for Kabiven?
Direct answer: The plastic container supplier is embedded in the packaging system qualification and is not reliably discoverable from general public sources without the product’s container system specification and regulatory packaging references for the exact presentation.
What container specs matter for parenteral nutrition bags?
For 3-in-1 plastic containers, qualification typically covers:
- Barrier properties for oxygen/water vapor
- Compatibility testing with amino acids, dextrose, lipid emulsion, and electrolytes
- Seals, weld integrity, and closure performance after handling
- Sterility assurance for the container system
Are there alternative suppliers for Kabiven due to shortages or recall events?
Direct answer: Substitutions during shortages occur at the level of MAH sourcing, contract manufacturing, and distribution swap, but a factual “alternative supplier” list cannot be produced without a dated shortage/recall event tied to a specific country and product code.
What is the most defensible way to identify Kabiven suppliers for procurement or contracting?
Direct answer: Procurement-grade supplier identification is done by mapping:
- Country and presentation (bag size, chamber configuration, strength)
- Labeled MAH on the carton and IFU
- Listed manufacturing site(s) and batch release site(s) on regulatory documentation
- Named contract packager and logistics provider where disclosed
A supplier list must be anchored to that label record.
Key Takeaways
- A complete, accurate supplier list for “KABIVEN IN PLASTIC CONTAINER” requires a specific geography and presentation to map the labeled MAH and listed manufacturing/batch release sites.
- Kabiven supply chains split across aseptic manufacturing, multi-chamber plastic container assembly, and secondary packaging and distribution.
- Container suppliers and packaging system vendors are not reliably assignable without regulatory packaging specifications for the exact presentation.
FAQs
- Who is the marketing authorization holder (MAH) for Kabiven in plastic container in my country?
- Which manufacturing site releases the batches for Kabiven 3-in-1 plastic bag presentations?
- Does Kabiven use the same plastic container supplier across all bag sizes and markets?
- What contract manufacturing model is used for parenteral nutrition multi-chamber plastic containers like Kabiven?
- How can procurement teams confirm the correct Kabiven supplier for a specific NDC or EU pack code?
References
No sources were cited because the required country/presentation-specific label and regulatory documents were not provided.
